Gene therapy for cystic fibrosis.

Davies JC, Geddes DM, Alton EW

The Journal Of Gene Medicine

J Gene Med. 2001 Sep-Oct;3(5):409-17.

Print this page

Cystic fibrosis (CF) is associated with significant morbidity and mortality, despite significant advances in conventional treatment. The field of gene therapy has progressed rapidly since the cystic fibrosis transmembrane conductance regulator (CFTR) gene was cloned. In this review we discuss current knowledge on the underlying molecular defect in CF, and the progress in gene transfer studies from the early in vitro work through to clinical trials, including the development of endpoints to assess efficacy. We highlight the problems encountered, and likely future directions of the field.

Go Back to Publications     View on Pubmed (11601754)    View on Google Scholar